| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/26/2002 | EP0644773B1 Anti-aids immunomodulator complex |
| 06/26/2002 | EP0574391B1 Antibodies against the urokinase receptor and their use |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355846A Method for down-regulating IL5 activity |
| 06/26/2002 | CN1355844A Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/26/2002 | CN1355714A LIM Mineralization protein splice variants |
| 06/26/2002 | CN1355712A Use of antibodies against CD2O for treatment of graft versus host disease |
| 06/26/2002 | CN1355711A Method for inhibiting brain tumor growth |
| 06/26/2002 | CN1355710A Combination vaccine against streptocouus pneumoniae and repiratory syncytial virus (RSV) |
| 06/26/2002 | CN1355709A Tumor vaccines |
| 06/26/2002 | CN1355704A Method for preparing membrane visicles |
| 06/26/2002 | CN1355690A Method for improving half-life of soluble viral-specific ligands on mucosal membranes |
| 06/26/2002 | CN1355253A Humanized genetically engineered neutralizing antibody of rabies virus |
| 06/26/2002 | CN1086589C Vaccines |
| 06/26/2002 | CN1086588C Pseudomonas active protein and method for producing same |
| 06/25/2002 | USRE37768 Useful as probes to diagnose the presence of haemophilus influenzae in samples. |
| 06/25/2002 | US6410824 Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 06/25/2002 | US6410775 APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies |
| 06/25/2002 | US6410721 Polynucleotide decoys that inhibit MHC-II expression and uses thereof |
| 06/25/2002 | US6410720 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 06/25/2002 | US6410719 Nuclelotide sequences coding adhesin for use in the treatment of gastrointestinal disorders and peptic ulcers |
| 06/25/2002 | US6410703 Identification of a vaccine candidate from an extraintestinal isolate of E. coli |
| 06/25/2002 | US6410697 Isolating mammalian glycoprotein; obtain sample with glycoprotein, incubate with antibody, apply solution to matrix, elute and recover mammalian glycoprotein |
| 06/25/2002 | US6410696 Cyclosporin immunoassay |
| 06/25/2002 | US6410691 Monoclonal antibody for use in diagnosis and treatment of immunlogical defects, cancer and rheumatic diseases |
| 06/25/2002 | US6410690 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 06/25/2002 | US6410688 Def1 |
| 06/25/2002 | US6410509 Antigen; induce immunology response |
| 06/25/2002 | US6410508 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 06/25/2002 | US6410507 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 06/25/2002 | US6410326 Destroying human tumor cells; obtain tumor cells, transform with replication defective vector, incubate with prodrug, monitor destruction of cells |
| 06/25/2002 | US6410318 Antibodies directed against binding-associated epitopes |
| 06/25/2002 | US6410311 Recombinant feline herpesvirus comprising a foreign DNA inserted into a region corresponding to a 3.0 kb EcoRI-SalI fragment of a feline herpesvirus genome |
| 06/25/2002 | US6410299 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410297 Processes for preparation of Marek's disease virus using continuous avian cell lines |
| 06/25/2002 | US6410286 Asparaginyl tRNA synthetase from Staphylococcus Aureus |
| 06/25/2002 | US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 06/25/2002 | US6410263 Histidine kinase |
| 06/25/2002 | US6410250 Sustained delivery device and methods of making and using the same |
| 06/25/2002 | US6410222 Immuniizng chicken eggs |
| 06/25/2002 | US6410033 Virus comprising foreign dna sequence inserted into genome which is capable of being expressed in infected host cell |
| 06/25/2002 | US6410032 Attenuated forms of bovine viral diarrhea virus |
| 06/25/2002 | US6410031 Attentuated porcine reproductive and respiratory syndrome virus strain and method of use |
| 06/25/2002 | US6410030 Polypeptide used as immunogenic element carried by peptide sequence between amino acid residues 130 and 230 of sequence of g protein of human respiratory syncytial virus of subgroups a and b, or of bovine respiratory syncytial virus |
| 06/25/2002 | US6410028 Administering complex of heat shock protein noncovalently bound to antigenic peptide or protein to elicit immune response, wherein complex is made in vitro, and antigenic peptide or protein is not isolated from complex |
| 06/25/2002 | US6410025 Polysaccharide precipitation process |
| 06/25/2002 | US6410024 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 06/25/2002 | US6410023 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 06/25/2002 | US6410022 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 06/25/2002 | US6410021 Vaccines of pasteurellaceae mutants and vaccination method |
| 06/25/2002 | US6410019 Topical administration of immunoglobulins brings about remission of inflammatory process without causing any toxic or unwanted side effects |
| 06/25/2002 | US6410013 Viral vectors for use in monitoring HIV drug resistance |
| 06/25/2002 | US6410009 Pharmaceutical composition for treating hepatitis B virus (HBV) infection |
| 06/25/2002 | CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 06/25/2002 | CA2123612C Hybrid protein between cs from plasmodium and h bsag |
| 06/25/2002 | CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/25/2002 | CA2006412C Eimeria tenella vaccine |
| 06/20/2002 | WO2002048715A2 Inflammatory markers for detection and prevention of diabetes mellitus |
| 06/20/2002 | WO2002048675A2 Improved compositions and methods for producing antibodies to low molecular weight analytes |
| 06/20/2002 | WO2002048391A2 Dormancy - induced mycobacterium proteins |
| 06/20/2002 | WO2002048388A2 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 06/20/2002 | WO2002048370A2 Compositions and methods relating to colon specific genes and proteins |
| 06/20/2002 | WO2002048368A2 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | WO2002048362A2 Embryogenesis associated proteins |
| 06/20/2002 | WO2002048358A2 Regulation of human chemokine-like receptor |
| 06/20/2002 | WO2002048185A2 Method for identifying secreted chlamydia polypeptides by using a type iii secretion system of a gram-negative |
| 06/20/2002 | WO2002048180A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
| 06/20/2002 | WO2002048175A2 Mhc class i associated peptides for prevention and treatment of tuberculosis |
| 06/20/2002 | WO2002047730A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | WO2002047728A2 Treatment of posterior capsule opacification |
| 06/20/2002 | WO2002047727A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | WO2002047721A1 Silensed anti-cd28 antibodies and use thereof |
| 06/20/2002 | WO2002047720A2 Treatment and prevention of ebv infection and ebv-associated disorders |
| 06/20/2002 | WO2002047719A2 Survical promoting ncam binding and ncam ligand biding compounds |
| 06/20/2002 | WO2002047718A2 Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) |
| 06/20/2002 | WO2002047703A2 Immune system stimulation |
| 06/20/2002 | WO2002047534A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/20/2002 | WO2002040518A8 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 06/20/2002 | WO2002031110A3 Hematopoietic stem cell gene therapy |
| 06/20/2002 | WO2002030320A3 Stimulation of thymus for vaccination development |
| 06/20/2002 | WO2002028905A3 Human anti-cd40 antibodies |
| 06/20/2002 | WO2002022077A3 Compositions and methods for inhibition of hiv-1 infection |
| 06/20/2002 | WO2002018426A3 Rabbit hemorrhagic disease vaccine and antigens |
| 06/20/2002 | WO2002016436A3 ANTIBODIES TO HUMAN IL-1$g(b) |
| 06/20/2002 | WO2002011669A3 Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof |
| 06/20/2002 | WO2002008393A3 Serine protease from yersinia enterocolitica |
| 06/20/2002 | WO2002004608A3 Regulation of human oligopeptidase a-like enzyme |
| 06/20/2002 | WO2002003911A8 Prevention and treatment of alzheimer's disease |
| 06/20/2002 | WO2002000711A3 Ev-vegf nucleic acids and polypeptides and methods of use |
| 06/20/2002 | WO2002000232A3 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 06/20/2002 | WO2001095933A3 Immunization through oral administration of a vaccine with an edible product |
| 06/20/2002 | WO2001092876A3 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 06/20/2002 | WO2001090191A3 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS |
| 06/20/2002 | WO2001090152A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/20/2002 | WO2001089281A3 Tumor-associated antigen (b132), characterized by seq. id. no. 2 |
| 06/20/2002 | WO2001087977A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 06/20/2002 | WO2001083524A3 Rna metabolism proteins |
| 06/20/2002 | WO2001081417A3 Use of taci as an anti-tumor agent |
| 06/20/2002 | WO2001074904A3 G-protein coupled receptors and nucleic acids encoding same |
| 06/20/2002 | WO2001072830A3 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |